The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis
Joint Authors
Karaarslan, Ahmet
Oksel, Fahrettin
Kobak, Şenol
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-11-12
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Rheumatoid arthritis (RA) is considered as a connective tissue disease while ankylosing spondylitis (AS) is a prototype of spondyloarthritis.
These diseases are seen concomitantly only very rarely.
Also, rituximab has proven efficacy in the treatment of RA while its role in the treatment of AS is unclear.
In this presentation, the concomitant presence of RA and AS in a 43-year-old male patient as well as the efficacy and safety of rituximab is discussed.
Rituximab was given due to lack of response to treatment with anti-TNF-alpha.
Evaluations made at the 6th and 12th months of treatment showed complete response for RA and partial response for AS.
American Psychological Association (APA)
Kobak, Şenol& Karaarslan, Ahmet& Oksel, Fahrettin. 2013. The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis. Case Reports in Rheumatology،Vol. 2013, no. 2013, pp.1-4.
https://search.emarefa.net/detail/BIM-498493
Modern Language Association (MLA)
Kobak, Şenol…[et al.]. The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis. Case Reports in Rheumatology No. 2013 (2013), pp.1-4.
https://search.emarefa.net/detail/BIM-498493
American Medical Association (AMA)
Kobak, Şenol& Karaarslan, Ahmet& Oksel, Fahrettin. The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis. Case Reports in Rheumatology. 2013. Vol. 2013, no. 2013, pp.1-4.
https://search.emarefa.net/detail/BIM-498493
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-498493
